Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China

By sjmartinez • September 13, 2023

Li Z, Zhang X, Ding L, Jing J, Gu HQ, Jiang Y, Meng X, Du C, Wang C, Wang M, Xu M, Zhang Y, Hu M, Li H, Gong X, Dong K, Zhao X, Wang Y, Liu L, Xian Y, Peterson E, Fonarow GC, Schwamm LH, Wang Y. Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China. Stroke Vasc Neurol. 2023 Sep 12:svn-2023-002411. doi: 10.1136/svn-2023-002411. Epub ahead of print. PMID: 37699726.

Tags: Cardiology/Epi, Publications, stroke

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]